GBI

GBI, operated by Shanghai Jibo Investment Management Consulting Co., Ltd., is the first healthcare information data provider in China. GBI has always been committed to driving value through data and technology, offering pharmaceutical companies, medical device firms, and industry-related service providers holographic data spanning the global drug lifecycle, industry insights, global news, and other high-value intelligence. This empowers enterprises to lead the market in strategic planning, product decision-making, and market insights. After 20 years of deep industry cultivation, GBI has become the preferred partner for over 95% of multinational pharmaceutical companies, leading domestic pharmaceutical companies, and consulting firms within the healthcare sector. GBI's main products include: SOURCE Drug Database, METRIX Researcher Database, DEVINT Medical Device Database, Global Market Access and Pricing Strategy, and Customized Consulting Services.